Joseph Summers
Family Medicine · Fountain Hills, AZNPI 1124203922
Payments from drug & device makers
Across 110 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$528
- Amgen$301
- Novo Nordisk$230
- AstraZeneca$114
- Boehringer Ingelheim$101
- Phathom Pharmaceuticals, Inc.$96
- plus $648 from 16 others
What the payments were for
- Food & beverage$1,98698%
- Education$312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $528 |
| Amgen | 17 | $301 |
| Novo Nordisk | 14 | $230 |
| AstraZeneca | 8 | $114 |
| Boehringer Ingelheim | 6 | $101 |
| Phathom Pharmaceuticals, Inc. | 3 | $96 |
| Pfizer | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Novartis | 3 | $69 |
| Abbott | 3 | $67 |
| Inspire Medical Systems, Inc. | 1 | $47 |
| Cleerly, Inc. | 1 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
| Currax Pharmaceuticals LLC | 2 | $41 |
| Medtronic | 1 | $32 |
| Lilly USA, LLC | 2 | $28 |
| Exact Sciences | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Aerin Medical Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Bausch Health US, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
How this compares
$2,017 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $24,288 |
| OzempicSemaglutide | 16 | $18,502 |
| NucyntaTapentadol Hcl | 14 | $17,339 |
| Celecoxib | 15 | $1,770 |
| Levothyroxine Sodium | 136 | $1,227 |
| Gabapentin | 29 | $794 |
| Nebivolol Hcl | 13 | $615 |
| Escitalopram Oxalate | 31 | $581 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $558 |
| Atorvastatin Calcium | 77 | $531 |
| Hydrocortisone | 15 | $464 |
| Allopurinol | 36 | $360 |
| Metoprolol Succinate | 36 | $346 |
| Mirtazapine | 12 | $329 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $24,28821 claims |
| Novo NordiskOzempic | $230 | $18,50216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Fountain Hills
- Matthew HummelFountain Hills$108K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
- Neil ShethChandler$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.